Cerebral Embolic Protection During TAVR: A Clinical Event Meta-Analysis

Journal of the American College of Cardiology

Volumn 69, Issue 4, 2017, Pages 465-466

  Giustino, Gennaro ^a   Sorrentino, Sabato ^a   Mehran, Roxana ^a   Faggioni, Michela ^a   Dangas, George ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; BRAIN EMBOLISM; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DISEASE SEVERITY; EMBOLIC PROTECTION DEVICE; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; LETTER; MORTALITY RISK; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SAMPLE SIZE; STUDY DESIGN; SYSTEMATIC REVIEW (TOPIC); TRANSCATHETER AORTIC VALVE IMPLANTATION; META ANALYSIS (TOPIC); PROCEDURES;

HUMANS; INTRACRANIAL EMBOLISM; META-ANALYSIS AS TOPIC; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85010440867     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.12.002     Document Type: Letter

References (5)

1. 1 Kapadia, S.R., Kodali, S., Makkar, R., et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 69 (2017), 367–377.
2. 2 Van Mieghem, N.M., van Gils, L., Ahmad, H., et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention 12 (2016), 499–507.
3. 3 Haussig, S., Mangner, N., Dwyer, M.G., et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 316 (2016), 592–601.
4. 4 Wendt, D., Kleinbongard, P., Knipp, S., et al. Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation. Ann Thorac Surg 100 (2015), 686–691.
5. 5 Lansky, A.J., Schofer, J., Tchetche, D., et al. A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J 36 (2015), 2070–2078.